Celsis sold its Analytical Services division to a trade buyer. The division, which is non-core to Celsis, provides outsourced analytical laboratory services to the pharmaceutical and consumer products industries.
Celsis now consists of two divisions – Rapid Detection and In-Vitro Technologies. Harwood Private Equity acquired the business in 2009 in a public-to-private transaction.